OR

Browse By

Complement C3a receptor, a novel therapeutic target for melanoma (2014–2015)

Grant type:
Cancer Council Queensland
Researchers:

  • Associate Professor Barbara Rolfe

    Principal Research Fellow and GL
    Australian Institute for Bioengineering and Nanotechnology
    Principal Research Fellow and Group
    Australian Institute for Bioengineering and Nanotechnology

  • Professor Andrew Barbour

    Professor
    Princess Alexandra Hospital Southside Clinical Unit
    Faculty of Medicine
    Professor
    Princess Alexandra Hospital Southside Clinical Unit
    Faculty of Medicine
    Affiliate Professor of Frazer Insti
    Frazer Institute
    Faculty of Medicine
Funded by:
Cancer Council Queensland